Alizée Lebeau
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
-
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 7
- Lymphatic System and Diseases 5
- Cancer Cells and Metastasis 2
- Cytokine Signaling Pathways and Interactions 1
-
- Adenosine and Purinergic Signaling 1
- Erythrocyte Function and Pathophysiology 1
- Co-authors
- Michaël HerfsPatrick RoncaratiPascale HubertDiane BruyèreMargot MeunierMarie‐Julie NokinMarie AncionStéphanie Demoulin
- Journals
- Cellular and Molecular Life Sciences (3 papers)Journal for ImmunoTherapy of Cancer (2 papers)Advances in experimental medicine and biology (1 paper)Cancer Treatment Reviews (1 paper)Circulation (1 paper)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Alizée Lebeau
11 papers receiving 211 citations
Peers
Comparison fields: 5 of 54
- Clinical Biochemistry 38
- Immunology 72
- Cancer Research 39
- Oncology 65
- Molecular Biology 83
Countries citing papers authored by Alizée Lebeau
This map shows the geographic impact of Alizée Lebeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alizée Lebeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alizée Lebeau more than expected).
Fields of papers citing papers by Alizée Lebeau
This network shows the impact of papers produced by Alizée Lebeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alizée Lebeau. The network helps show where Alizée Lebeau may publish in the future.
Co-authors
The 25 scholars most cited alongside Alizée Lebeau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 15 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 15 | |
| 9 | 2021 | 129 | |
| 10 | 2021 | 7 | |
| 11 | 2016 | 26 |
About Alizée Lebeau
Alizée Lebeau is a scholar working on Oncology, Physiology, Clinical Biochemistry, Immunology and Cancer Research, having authored 11 papers that have together received 212 indexed citations. Recurring topics across this work include Lymphatic System and Diseases (5 papers), Angiogenesis and VEGF in Cancer (2 papers), Cancer Cells and Metastasis (2 papers), Adenosine and Purinergic Signaling (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Phagocytosis and Immune Regulation (1 paper), Body Contouring and Surgery (1 paper) and Erythrocyte Function and Pathophysiology (1 paper). The work is most often cited by research in Clinical Biochemistry (38 citations), Immunology (72 citations), Cancer Research (39 citations), Oncology (65 citations) and Molecular Biology (83 citations). Alizée Lebeau has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Michaël Herfs, Patrick Roncarati, Pascale Hubert, Diane Bruyère, Margot Meunier, Marie‐Julie Nokin, Marie Ancion, Stéphanie Demoulin, Coraline Radermecker and Elodie Hendrick. Their work appears in journals such as Cellular and Molecular Life Sciences, Journal for ImmunoTherapy of Cancer, Advances in experimental medicine and biology, Cancer Treatment Reviews and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.